Cargando…
Second-generation aptamer-conjugated PSMA-targeted delivery system for prostate cancer therapy
BACKGROUND: miR-15a and miR-16-1 have been identified as tumor suppressor genes in prostate cancer, but their safe and effective delivery to target cells is key to the successful use of this therapeutic strategy. RNA aptamer A10 has been used as a ligand, targeting prostate cancer cells that express...
Autores principales: | Wu, Xin, Ding, Baoyue, Gao, Jing, Wang, Huanyun, Fan, Wei, Wang, Xiang, Zhang, Wei, Wang, Xiaoyu, Ye, Lihua, Zhang, Min, Ding, Xueying, Liu, Jiyong, Zhu, Quangang, Gao, Shen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3184934/ https://www.ncbi.nlm.nih.gov/pubmed/21980237 http://dx.doi.org/10.2147/IJN.S23747 |
Ejemplares similares
-
Study on the prostate cancer-targeting mechanism of aptamer-modified nanoparticles and their potential anticancer effect in vivo
por: Wu, Xin, et al.
Publicado: (2014) -
Degradable gene delivery systems based on Pluronics-modified low-molecular-weight polyethylenimine: preparation, characterization, intracellular trafficking, and cellular distribution
por: Fan, Wei, et al.
Publicado: (2012) -
Anti-DR5 monoclonal antibody-mediated DTIC-loaded nanoparticles combining chemotherapy and immunotherapy for malignant melanoma: target formulation development and in vitro anticancer activity
por: Ding, Baoyue, et al.
Publicado: (2011) -
Aptamer‐conjugated mesoporous polydopamine for docetaxel targeted delivery and synergistic photothermal therapy of prostate cancer
por: Dai, Liang, et al.
Publicado: (2021) -
Reduction-responsive cross-linked stearyl peptide for effective delivery of plasmid DNA
por: Yao, Chong, et al.
Publicado: (2015)